ConductScience.org, home

Paper7658282

Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin.

Weiss H and 4 others. J Pediatr, 1995. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. Papers, record 7658282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7658282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin.
PubMed
Journal
J Pediatr
PubMed
Year
1995
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
3.17
iCite
Revised in PubMed
2019-06-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Weiss HH
2Cooper BB
3Brook MM
4Schlueter MM
5Clyman RR

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ductus Arteriosus, PatentMajor topic
IndomethacinMajor topic
Ductus Arteriosus
Echocardiography
Female
Gestational Age
Humans
Infant, Newborn
Infant, Premature
Male
Recurrence
Statistics as Topic
Time Factors

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HL 46691NHLBI NIH HHSUnited StatesR01HL046691PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03022253Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm NeonatesBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in8627452Reopening of the ductus arteriosus after closure with indomethacin: importance of sustained effective indomethacin serum concentrations.https://conductscience.org/library/papers/8627452

Source PubMed

Download CSV of comments and corrections

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
36937978Association between endotypes of prematurity and pharmacological closure of patent ductus arteriosus: A systematic review and meta-analysis.Front Pediatr2023https://conductscience.org/library/papers/36937978PubMed
35887640Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.J Pers Med2022https://conductscience.org/library/papers/35887640PubMed
31236021Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants.Turk Pediatri Ars2018https://conductscience.org/library/papers/31236021PubMed
29276647Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports.AJP Rep2017https://conductscience.org/library/papers/29276647PubMed
27146832Intravenous paracetamol for PDA closure in the preterm: a single-center experience.Eur J Pediatr2016https://conductscience.org/library/papers/27146832PubMed
26396694High-Dose Oral Ibuprofen in Treatment of Patent Ductus Arteriosus in Full-Term Neonates.Iran J Pediatr2015https://conductscience.org/library/papers/26396694PubMed
25856764Predictors of successful closure of patent ductus arteriosus with indomethacin.J Perinatol2015https://conductscience.org/library/papers/25856764PubMed
25346899Surgical Ligation on Significant Patent Ductus Arteriosus in Very Low Birth Weight Infants: Comparison between Early and Late Ligations.Korean J Thorac Cardiovasc Surg2014https://conductscience.org/library/papers/25346899PubMed
24435507Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.Pediatr Cardiol2014https://conductscience.org/library/papers/24435507PubMed
23543527Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23543527PubMed
23055893Optimum Use of Therapeutic Drug Monitoring and Pharmacokinetics-Pharmacodynamics in the NICU.J Pediatr Pharmacol Ther2009https://conductscience.org/library/papers/23055893PubMed
23055885Patent ductus arteriosus: indomethacin, Ibuprofen, surgery, or no treatment at all?J Pediatr Pharmacol Ther2009https://conductscience.org/library/papers/23055885PubMed
22864766Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus.Eur J Pediatr2012https://conductscience.org/library/papers/22864766PubMed
22564132Patent ductus arteriosus in premature neonates.Drugs2012https://conductscience.org/library/papers/22564132PubMed
22368592The persistently patent arterial duct in the premature infant.Images Paediatr Cardiol2001https://conductscience.org/library/papers/22368592PubMed
22341541Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.Clin Perinatol2012https://conductscience.org/library/papers/22341541PubMed
22307401Improved closure of patent ductus arteriosus with high doses of ibuprofen.Pediatr Cardiol2012https://conductscience.org/library/papers/22307401PubMed
21195414Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment.J Pediatr2011https://conductscience.org/library/papers/21195414PubMed
20063159Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability.Pediatr Cardiol2010https://conductscience.org/library/papers/20063159PubMed
17251986Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?J Perinatol2007https://conductscience.org/library/papers/17251986PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7658282

GET https://conductscience.org/api/papers/v1/7658282/cited_by?page=2